Largest pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceutical companies ranked by net assets, at SEK 878.5B, ahead of Johnson & Johnson (SEK 828.4B) and Sanofi (SEK 804.5B). Figures as of 18 Nov 2026, 18:19 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerSEK 878.5B
- Median
- SEK 8.9B
- Combined market value
- SEK 51.75T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SEK 878.5B | SEK 1.63T | SEK 286.42 | 0.97% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SEK 828.4B | SEK 6.75T | SEK 2,802.71 | 1.00% down | 38% up | ||
| 3 | SanofiSNY · Health Care | SEK 804.5B | SEK 1.15T | SEK 480.85 | 0.41% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | SEK 534.4B | SEK 3.48T | SEK 1,409.63 | 3.21% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | SEK 529.6B | SEK 1.84T | SEK 1,063.64 | 0.00% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | SEK 494.4B | SEK 2.83T | SEK 1,825.47 | 1.41% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | SEK 472.7B | SEK 694.9B | SEK 217.49 | 1.06% down | 54% up | ||
| 8 | NovartisNVS · Health Care | SEK 468.6B | SEK 2.99T | SEK 1,584.56 | 1.98% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | SEK 317.5B | SEK 996.7B | SEK 9,635.21 | 0.97% down | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | SEK 292.5B | SEK 1.77T | SEK 402.53 | 2.64% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | SEK 269.6B | SEK 12.62T | SEK 14,173.32 | 1.44% down | 35% up | ||
| 12 | GSKGSK · Health Care | SEK 220.8B | SEK 994.1B | SEK 495.93 | 0.85% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | SEK 189.6B | SEK 1.38T | SEK 5,462.28 | 0.66% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | SEK 187.7B | SEK 1.25T | SEK 610.93 | 1.97% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | SEK 149.4B | SEK 241.1B | SEK 210.33 | 1.25% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | SEK 98.7B | SEK 405.3B | SEK 704.89 | 1.03% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 80.4B | SEK 499.7B | SEK 428.28 | 1.08% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | SEK 72.1B | SEK 252B | SEK 5,916.77 | 0.28% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | SEK 66.5B | SEK 137B | SEK 274.02 | 4.35% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | SEK 61.8B | SEK 119.3B | SEK 615.85 | 3.61% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | SEK 59.4B | SEK 58.5B | SEK 85.94 | 1.97% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | SEK 59.4B | SEK 322.6B | SEK 523.21 | 0.88% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | SEK 46B | SEK 283.9B | SEK 391.81 | 0.36% down | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | SEK 44.3B | SEK 470.9B | SEK 4,122.59 | 1.80% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 43.9B | SEK 160.9B | SEK 2,505.98 | 2.48% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 40.8B | SEK 127.3B | SEK 152.73 | 1.66% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | SEK 33.8B | SEK 351.9B | SEK 866.01 | 2.12% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | SEK 18.5B | SEK 80B | SEK 476.33 | 3.17% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | SEK 10.3B | SEK 60.9B | SEK 3,044.38 | 2.00% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | SEK 10.2B | SEK 32B | SEK 164.77 | 0.68% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | SEK 8.9B | SEK 87.5B | SEK 3,129.91 | 1.00% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | SEK 8B | SEK 205.6B | SEK 1,535.19 | 3.43% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | SEK 7.8B | SEK 64.9B | SEK 1,596.80 | 0.34% down | 31% up | ||
| 34 | InsmedINSM · Health Care | SEK 7.5B | SEK 268.6B | SEK 1,224.14 | 1.11% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | SEK 7.3B | SEK 93.2B | SEK 981.20 | 2.96% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | SEK 6.7B | SEK 85.7B | SEK 107.12 | 1.17% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | SEK 6.6B | SEK 101.5B | SEK 671.42 | 5.40% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | SEK 6.6B | SEK 76B | SEK 694.63 | 2.41% down | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | SEK 6.5B | SEK 49.7B | SEK 285.76 | 1.01% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | SEK 6.2B | SEK 83.1B | SEK 1,273.66 | 0.57% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 6.1B | SEK 96B | SEK 4,134.63 | 3.55% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 5.8B | SEK 76B | SEK 967.49 | 0.14% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | SEK 5.3B | SEK 46.4B | SEK 424.01 | 0.71% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | SEK 5.1B | SEK 74.4B | SEK 849.55 | 1.86% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | SEK 5B | SEK 49.8B | SEK 884.39 | 0.09% up | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | SEK 5B | SEK 46.5B | SEK 279.36 | 2.00% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | SEK 4.8B | SEK 66.6B | SEK 981.25 | 0.29% up | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 4.7B | SEK 62.5B | SEK 442.40 | 1.30% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | SEK 3.4B | SEK 40.2B | SEK 293.68 | 1.60% down | 169% up | ||
| 50 | ErascaERAS · Health Care | SEK 3.3B | SEK 47.3B | SEK 134.90 | 4.39% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | SEK 3.2B | SEK 61.1B | SEK 936.66 | 0.28% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.4B | SEK 83.6B | SEK 1,205.86 | 1.80% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | SEK 1.2B | SEK 49.8B | SEK 518.99 | 0.02% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | SEK 896.9M | SEK 71.8B | SEK 1,365.80 | 1.10% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -SEK 719.2M | SEK 77.9B | SEK 223.69 | 4.26% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -SEK 1.2B | SEK 53.2B | SEK 1,260.41 | 1.25% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -SEK 1.8B | SEK 181.2B | SEK 2,762.23 | 0.27% up | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -SEK 2.1B | SEK 51.2B | SEK 613.31 | 0.02% up | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -SEK 6.7B | SEK 72.8B | SEK 522.85 | 0.35% down | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -SEK 21.2B | SEK 154.5B | SEK 793.17 | 1.67% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -SEK 33.2B | SEK 5.17T | SEK 2,925.12 | 1.66% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1584 SEK).
Questions and answers
Which pharmaceutical companies rank first by net assets?
Pfizer (SEK 878.5B), Johnson & Johnson (SEK 828.4B) and Sanofi (SEK 804.5B) are the top three of the 61 pharmaceutical companies ranked by net assets as of 18 Nov 2026, 18:19 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by net assets have a combined market value of SEK 51.75T as of 18 Nov 2026, 18:19 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.